[Table/Fig-2]:
Parameters | N-N | N-D | A-N | A-D | Chi square test | RE | RUE | Relative Risk | p-value |
---|---|---|---|---|---|---|---|---|---|
nRBC’s | 83 | 15 | 11 | 44 | 62.23 | 80% | 15.3% | 5.23 | < 0.001* |
Total Count | 44 | 01 | 50 | 58 | 35.53 | 53.7% | 2.2% | 24.4 | < 0.001* |
ANC | 77 | 01 | 17 | 58 | 93.34 | 77.3% | 1.3% | 59.46 | < 0.001* |
I/T ratio | 69 | 02 | 25 | 57 | 71.45 | 69.51 | 2.8% | 24.82 | < 0.001* |
I/M ratio | 66 | 02 | 28 | 57 | 65.55 | 67.1% | 2.9% | 23.13 | < 0.001* |
Neut Morp | 88 | 18 | 06 | 41 | 56.8 | 95.3% | 34.8% | 2.74 | < 0.001* |
Platelet Count | 76 | 39 | 18 | 20 | 4.22 | 52.6% | 33.9% | 1.55 | <0.05 |
microESR | 62 | 03 | 32 | 56 | 54.97 | 54.9% | 4.6% | 11.9 | < 0.001* |
* Highly significant